1. Home
  2. SXTP vs BYAH Comparison

SXTP vs BYAH Comparison

Compare SXTP & BYAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$0.49

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Logo Park Ha Biological Technology Co. Ltd. Ordinary Shares

BYAH

Park Ha Biological Technology Co. Ltd. Ordinary Shares

HOLD

Current Price

$1.53

Market Cap

1.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXTP
BYAH
Founded
2010
2016
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.9M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
SXTP
BYAH
Price
$0.49
$1.53
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $3.70
N/A
AVG Volume (30 Days)
★ 321.8K
146.0K
Earning Date
11-27-2026
07-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 36.77
N/A
EPS
N/A
★ N/A
Revenue
★ $1,005,471.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$70.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 65.49
N/A
52 Week Low
$0.34
$0.05
52 Week High
$8.62
$6.64

Technical Indicators

Market Signals
Indicator
SXTP
BYAH
Relative Strength Index (RSI) 29.77 33.69
Support Level N/A $1.00
Resistance Level $1.01 $3.26
Average True Range (ATR) 0.11 0.35
MACD -0.03 -0.07
Stochastic Oscillator 6.02 6.06

Price Performance

Historical Comparison
SXTP
BYAH

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

About BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.

Share on Social Networks: